Skip to main content Deutsch

Projects

Institute of Medical Statistics

Third-party funded research projects of the Institute of Medical Statistics:

ProjectProject managementProject titleProject duration
ITN-Projekt Share-CTDMartin PoschSharing and Re-Using Clinical Trial Data to Maximise Impact1.1.2024–31.12.2027
INVENTSMartin Posch, Franz KönigInnovative Designs, Extrapolation, Simulation Methods and Evidence-Tools for Rare Diseases Addressing Regulatory Needs1.1.2024–31.12.2028
Horizon Europe – DEFINITIVERobin Ristl (Leader of WP4: Data analysis)Diagnostic HER2DX-Guided Treatment for Patients with Early-Stage HER2-Positive Breast Cancer1.12.2023–30.11.2028
Quality Control Measures for Biomedical Animal Studies (Bürgermeisterfond)Florian FrommletQuality Control Measures for Biomedical Animal Studies1.5.2023–30.4.2024
eWHORM – Enabling the WHO-Road Map 2030MUW: Bertrand Lell (Lead), Sonja Zehetmayer, Martin PoschEU project to reduce the burden of disease associated with worm infections in Sub Saharan Africa1.4.2023–31.3.2028
IMI – EU-PEARLFranz König, Martin PoschEU patient-centric clinical trial platform1.11.2019–30.4.2023
European Joint Programme on Rare Diseases (EJP RD)Franz König, Martin PoschApplication of improved statistical methodologies for clinical trials in Progressive Supranuclear Palsy24 months
nutritionDayMichael Hiesmayr(nDay) studyongoing
FWF (KLI 754)Manfred HeckingSex Differences in Kidney Disease Identification & Treatment1.3.2019–28.2.2022
EU – Horizon 2020Franz König (Deputy Coordinator, WP-Leader)IDEAS (Improving Design, Evaluation and Analysis of early drug development Studies)1.1.2015–31.12.2018
MRCGemeinsames Projekt mit Lancaster University, UK (Thomas Jaki), MedUni Wien: Martin PoschHMT: Accuracy vs. Precision – Developing optimal estimators for trials with multiple hypothesis tests1.10.2014–30.9.2017
EU-FP7Martin Posch (Leader of WP 3: Research in confirmatory trials for small populations and personalised medicines)Inspire (Innovative methodology for small populations research)1.2.2014–31.5.2017
EU-FP7Franz König (Leader of WP 4: Adaptive designs)IDEAL (Integrated DEsign and AnaLysis of small populations)1.11.2013–31.10.2016
EU-FP7Martin Posch (Leader of WP 2: New and improved methods for individual trial design)ASTERIX (Advances in Small Trials dEsign for Regulatory Innovation and eXcellence)1.10.2013–30.9.2017
FWF (Austrian Science Fund) and JSPS (Japan Society for the Promotion of Science)Martin PoschJoint Seminar "Innovative Clinical Trial Designs for Accelerating Medical Product Development"März 2015
ASDIPhilipp Metnitz (ASDI) and Alexandra GrafASDI: Zertifizierung von Intensivstationen1.1.2011–
FWF Erwin Schrödinger Program Nr. J 3721Florian KlinglmüllerPermutation Tests for Adaptive Clinical Trials14.05.2015–13.05.2016
FWF-Projekt P23167Martin PoschHypothesis Testing and Estimation in Adaptive Designs with Blinded and Unblinded Interim Analysis1.10.2010–31.10.2015
WWTF-Mathematics und ... Call 2009 – MA09-007Florian FrommletOptimal Selection Procedures in Genome Wide Association Studies1.3.2010–31.8.2014
FWF-Erwin-Schrödinger-Stipendium Nr. J3344-N26Alexandra GrafType 1 Error Rate Inflation in Multi-Armed Clinical Trials1.12.2012–30.11.2013
FWF-Hertha-Firnberg-Programm T-401Sonja ZehetmayerWiederholte Signifikanztests bei Kontrolle der False Discovery Rate1.6.2009–31.10.2012
FWF-Projekt P21763Werner BrannathComputational Methods for Adaptive and Multiple InferenceNovember 2009 bis Oktober 2012
British CouncilAT: Martin Posch & Franz KönigAcademic Research Collaboration „Optimal Adaptive Trials with Treatment Selection“2007
FWF-Projekt P18698-N15Peter BauerAdaptive Designs – Evaluation and New ApplicationsMai 2006 bis Oktober 2009
FWF-Projekt P15853-N04Peter BauerEvaluation of Adaptive Design ProceduresMai 2003 bis April 2006
FWF-Erwin-Schrödinger-Stipendium J2065Werner BrannathResampling bei Konfidenzintervallen für adaptive Designs1.9.2001–31.10.2002